Cite
Raney RB, Maurer HM, Anderson JR, et al. The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols. Sarcoma. 2001;5(1):9-15doi: 10.1080/13577140120048890.
Raney, R. B., Maurer, H. M., Anderson, J. R., Andrassy, R. J., Donaldson, S. S., Qualman, S. J., Wharam, M. D., Wiener, E. S., & Crist, W. M. (2001). The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols. Sarcoma, 5(1), 9-15. https://doi.org/10.1080/13577140120048890
Raney, R B, et al. "The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols." Sarcoma vol. 5,1 (2001): 9-15. doi: https://doi.org/10.1080/13577140120048890
Raney RB, Maurer HM, Anderson JR, Andrassy RJ, Donaldson SS, Qualman SJ, Wharam MD, Wiener ES, Crist WM. The Intergroup Rhabdomyosarcoma Study Group (IRSG): Major Lessons From the IRS-I Through IRS-IV Studies as Background for the Current IRS-V Treatment Protocols. Sarcoma. 2001;5(1):9-15. doi: 10.1080/13577140120048890. PMID: 18521303; PMCID: PMC2395450.
Copy
Download .nbib